Premier Research Group

Premier Research is a specialized, mid-sized global CRO with a strong focus on complex and innovative therapeutic areas such as oncology, rare disease, neuroscience, and cell & gene therapy. The company positions itself as a strategic partner, offering technology-powered solutions to accelerate clinical development from molecule to market. Its business model is service-based, generating revenue by providing clinical trial management, regulatory strategy, and consulting services to biopharma and medtech sponsors. As a private company, it competes in the crowded CRO market by leveraging deep therapeutic expertise in high-need, scientifically challenging domains.

Integrated suite of clinical trial service capabilities emphasizing technology-powered solutions, including Risk-Based Quality Management (RBQM), Real-World Evidence (RWE) & Artificial Intelligence (AI) operationalization, risk-based Trial Master File (TMF) oversight, and data analytics for operational intelligence.

Operates in the highly competitive global CRO market, competing against large full-service players (e.g., IQVIA, ICON, Labcorp), public mid-sized CROs, and other specialized boutique firms. Differentiation is based on deep therapeutic expertise in complex areas, technology-enabled services, and strategic consulting capabilities.